Clinical Trials Logo
  1. Home
  2. Airway Remodeling
  3. NCT03842839

Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography

Airway Remodeling Clinical Trial

Official title:
Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography

Clinical Trial Summary

The study aims to explore the effect of tiotropium on airway remodeling by using Endobronchial Optical Coherence Tomography (EB-OCT). We enrolled patients with GOLD I stage COPD. All the patients will be divided into four groups randomly to receive SABA as needed with or without regular use of tiotropium. Changes of airway morphology (accessed by EB-OCT), pulmonary function, QOL, and SABA usage will be obtained.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03842839
Study type Interventional
Source Guangzhou Institute of Respiratory Disease
Contact
Status Recruiting
Phase N/A
Start date October 1, 2018
Completion date December 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05573919 - VivAer: A Correlation Between Symptom Scores and Objective Findings N/A
Completed NCT04765761 - Proseal Laryngeal Mask Airway With or Without Introducer-tool Stabilization for Pressure Controlled Ventilation N/A
Recruiting NCT06288516 - BenRalizumab Effect on Airway Remodeling in Severe asTHma Phase 4
Enrolling by invitation NCT05692362 - Measure Airway Compliance by Endobronchial Optical Coherence Tomography
Completed NCT02566291 - Observational Study With Investigation of Two Second Generation Laryngeal Masks N/A
Completed NCT01178229 - Physiotherapy on the Airway of Bruxist Children Phase 1/Phase 2
Completed NCT06236971 - Effect of Lateral Positions on the Shape of Upper Airway
Terminated NCT01505933 - Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine Phase 2
Recruiting NCT05550402 - Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) N/A